Logo image of ATMC

ALPHATIME ACQUISITION CORP (ATMC) Stock Fundamental Analysis

NASDAQ:ATMC - Nasdaq - KYG0223V1059 - Common Stock - Currency: USD

11.65  +0.04 (+0.34%)

Fundamental Rating

0

Taking everything into account, ATMC scores 0 out of 10 in our fundamental rating. ATMC was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of ATMC have multiple concerns. ATMC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ATMC was profitable.
In the past year ATMC has reported a negative cash flow from operations.
ATMC Yearly Net Income VS EBIT VS OCF VS FCFATMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA 2.74%
ROE 3.04%
ROIC N/A
ROA(3y)0.11%
ROA(5y)N/A
ROE(3y)-19.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATMC Yearly ROA, ROE, ROICATMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATMC Yearly Profit, Operating, Gross MarginsATMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, ATMC has more shares outstanding
ATMC has a worse debt/assets ratio than last year.
ATMC Yearly Shares OutstandingATMC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
ATMC Yearly Total Debt VS Total AssetsATMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

ATMC has an Altman-Z score of 8.78. This indicates that ATMC is financially healthy and has little risk of bankruptcy at the moment.
ATMC has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.78
ROIC/WACCN/A
WACCN/A
ATMC Yearly LT Debt VS Equity VS FCFATMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

ATMC has a Current Ratio of 0.01. This is a bad value and indicates that ATMC is not financially healthy enough and could expect problems in meeting its short term obligations.
ATMC has a Quick Ratio of 0.01. This is a bad value and indicates that ATMC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ATMC Yearly Current Assets VS Current LiabilitesATMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

0

3. Growth

3.1 Past

ATMC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.32%.
EPS 1Y (TTM)7.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATMC Yearly Revenue VS EstimatesATMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
ATMC Yearly EPS VS EstimatesATMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 58.25, ATMC can be considered very expensive at the moment.
Compared to an average S&P500 Price/Earnings ratio of 29.35, ATMC is valued quite expensively.
Industry RankSector Rank
PE 58.25
Fwd PE N/A
ATMC Price Earnings VS Forward Price EarningsATMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATMC Per share dataATMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ATMC!.
Industry RankSector Rank
Dividend Yield N/A

ALPHATIME ACQUISITION CORP

NASDAQ:ATMC (3/7/2025, 8:06:03 PM)

11.65

+0.04 (+0.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners56.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap80.04M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 58.25
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.66
P/tB 1.66
EV/EBITDA N/A
EPS(TTM)0.2
EY1.72%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS7
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.74%
ROE 3.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.11%
ROA(5y)N/A
ROE(3y)-19.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 8.78
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-248.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A